CRH Medical (CRHM) Announces Quarterly Earnings Results

CRH Medical (NYSEAMERICAN:CRHM) issued its quarterly earnings data on Wednesday. The company reported $0.02 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.02, reports. The business had revenue of $32.02 million for the quarter, compared to analysts’ expectations of $31.40 million.

Shares of NYSEAMERICAN CRHM opened at $2.97 on Friday. CRH Medical has a 52 week low of $2.40 and a 52 week high of $4.50.

Several analysts have recently weighed in on the stock. Zacks Investment Research raised shares of CRH Medical from a “sell” rating to a “hold” rating in a report on Wednesday, December 12th. TD Securities reaffirmed a “buy” rating on shares of CRH Medical in a report on Tuesday, January 8th.

Several hedge funds and other institutional investors have recently made changes to their positions in CRHM. ClariVest Asset Management LLC acquired a new position in CRH Medical during the third quarter worth about $154,000. Acadian Asset Management LLC acquired a new position in CRH Medical during the third quarter worth about $354,000. Two Sigma Advisers LP raised its position in CRH Medical by 12.6% during the fourth quarter. Two Sigma Advisers LP now owns 220,300 shares of the company’s stock worth $675,000 after acquiring an additional 24,700 shares during the last quarter. Ativo Capital Management LLC raised its position in shares of CRH Medical by 7.1% in the third quarter. Ativo Capital Management LLC now owns 300,079 shares of the company’s stock valued at $1,185,000 after buying an additional 20,002 shares during the last quarter. Finally, Mackenzie Financial Corp purchased a new stake in CRH Medical in the fourth quarter valued at approximately $1,413,000.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by WKRB News and is the property of of WKRB News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at

CRH Medical Company Profile

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Read More: Dividend

Earnings History for CRH Medical (NYSEAMERICAN:CRHM)

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with's FREE daily email newsletter.